
    
      A single-arm post-market follow up study (PMCF) comparing the DESyne X2 PMCF data to the
      historic DESyne acute performance data to confirm the performance of the DESyne X2 Novolimus
      Eluting Coronary Stent System with regards to the residual risks of lesion access and acute
      device implantation through visually-assessed angiographic endpoints and physician feedback.
    
  